References
(1) Crawford S, Boulet SL, Kawwass JF, Jamieson DJ, Kissin DM. Cryopreserved oocyte versus fresh oocyte assisted reproductive technology cycles, United States, 2013. Fertil Steril 2017;107(1):110-118.
(2) Jones BP, Saso S, Mania A, Smith JR, Serhal P, Ben Nagi J. The dawn of a new ice age: social egg freezing. Acta Obstet Gynecol Scand 2018;97(6):641-647.
(3) Jones BP, Serhal P, Ben‐Nagi J. Social egg freezing should be offered to single women approaching their late thirties: FOR: Women should not suffer involuntary childlessness because they have not yet found a partner. BJOG: An International Journal of Obstetrics & Gynaecology 2018;125(12):1579-1579.
(4) Jones BP, Kasaven L, L’Heveder A, Jalmbrant M, Green J, Makki M, et al. Perceptions, outcomes, and regret following social egg freezing in the UK; a cross‐sectional survey. Acta Obstet Gynecol Scand . 2020;99(3):324-332. doi:10.1111/aogs.13763
(5) Nicoletti C, Tanturri ML. Differences in delaying motherhood across European countries: Empirical evidence from the ECHP. European Journal of Population/Revue européenne de Démographie 2008;24(2):157-183.
(6) Martinelli L, Busatta L, Galvagni L, Piciocchi C. Social egg freezing: a reproductive chance or smoke and mirrors? Croat Med J 2015 Aug;56(4):387-391.
(7) Cobo A, Garrido N, Pellicer A, Remohí J. Six years’ experience in ovum donation using vitrified oocytes: report of cumulative outcomes, impact of storage time, and development of a predictive model for oocyte survival rate. Fertil Steril 2015;104(6):1426-1434. e8.
(8) Devesa M, Tur R, Rodríguez I, Coroleu B, Martínez F, Polyzos NP. Cumulative live birth rates and number of oocytes retrieved in women of advanced age. A single centre analysis including 4500 women≥ 38 years old. Human Reproduction 2018;33(11):2010-2017.
(9) Al-Azemi M, Killick SR, Duffy S, Pye C, Refaat B, Hill N, et al. Multi-marker assessment of ovarian reserve predicts oocyte yield after ovulation induction. Human reproduction 2010;26(2):414-422.
(10) Fedorcsák P, Dale PO, Storeng R, Ertzeid G, Bjercke S, Oldereid N, et al. Impact of overweight and underweight on assisted reproduction treatment. Human Reproduction 2004;19(11):2523-2528.
(11) Nelson SM, Klein BM, Arce J. Comparison of antimüllerian hormone levels and antral follicle count as predictor of ovarian response to controlled ovarian stimulation in good-prognosis patients at individual fertility clinics in two multicenter trials. Fertil Steril 2015;103(4):923-930. e1.
(12) Vaughan DA, Harrity C, Sills ES, Mocanu EV. Serum estradiol: oocyte ratio as a predictor of reproductive outcome: an analysis of data from> 9000 IVF cycles in the Republic of Ireland. J Assist Reprod Genet 2016;33(4):481-488.
(13) El-Shawarby SA, Khalaf Y. Age-specific serum FSH concentrations and their correlation with the outcome of ovarian stimulation for IVF. Reproductive biomedicine online 2009;18(6):750-755.
(14) Wirleitner B, Okhowat J, Vištejnová L, Králíčková M, Karlíková M, Vanderzwalmen P, et al. Relationship between follicular volume and oocyte competence, blastocyst development and live‐birth rate: optimal follicle size for oocyte retrieval. Ultrasound in Obstetrics & Gynecology 2018;51(1):118-125.
(15) Ben-Nagi J, Wells D, Doye K, Loutradi K, Exeter H, Drew E, et al. Karyomapping: a single centre’s experience from application of methodology to ongoing pregnancy and live-birth rates. Reproductive BioMedicine Online 2017;35(3):264-271.
(16) Jenkins J, Drakeley A, Mathur R. The Management of Ovarian Hyperstimulation Syndrome.RCOG Green Top Guideline no.5, 2006.Reconfirmed 2011.
(17) Majumder K, Gelbaya TA, Laing I, Nardo LG. The use of anti-Müllerian hormone and antral follicle count to predict the potential of oocytes and embryos. European Journal of Obstetrics & Gynecology and Reproductive Biology 2010;150(2):166-170.
(18) Moreau J, Gatimel N, Simon C, Cohade C, Lesourd F, Parinaud J, et al. Age-specific anti-Mullerian hormone (AMH) levels poorly affects cumulative live birth rate after intra-uterine insemination. European Journal of Obstetrics & Gynecology and Reproductive Biology: X 2019;3:100043.
(19) Broer S, Dolleman M, Opmeer B, Fauser B, Mol B, Broekmans F. AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis. Hum Reprod Update 2010;17(1):46-54.
(20) Meczekalski B, Czyzyk A, Kunicki M, Podfigurna-Stopa A, Plociennik L, Jakiel G, et al. Fertility in women of late reproductive age: the role of serum anti-Müllerian hormone (AMH) levels in its assessment. J Endocrinol Invest 2016;39(11):1259-1265.
(21) Barad D, Weghofer A, Goyal A, Gleicher N. Age specific anti-müllerian hormone (AMH) levels discriminate at each age between poorer and better oocyte yields. Fertil Steril 2009;92(3):S101.
(22) Wittemer C, Ohl J, Bailly M, Bettahar-Lebugle K, Nisand I. Does body mass index of infertile women have an impact on IVF procedure and outcome? J Assist Reprod Genet 2000;17(10):547-552.
(23) Zhang JJ, Feret M, Chang L, Yang M, Merhi Z. Obesity adversely impacts the number and maturity of oocytes in conventional IVF not in minimal stimulation IVF. Gynecological Endocrinology 2015;31(5):409-413.
(24) Christensen MW, Ingerslev HJ, Degn B, Kesmodel US. Effect of female body mass index on oocyte quantity in fertility treatments (IVF): treatment cycle number is a possible effect modifier. A register-based cohort study. PloS one 2016;11(9):e0163393.
(25) Cobo A, García-Velasco JA, Coello A, Domingo J, Pellicer A, Remohí J. Oocyte vitrification as an efficient option for elective fertility preservation. Fertil Steril 2016;105(3):755-764. e8.
(26) Wennberg A, Schildauer K, Brännström M. Elective oocyte freezing for non‐medical reasons; a six‐year report on utilization and IVF results from a Swedish center. Acta obstetricia et gynecologica Scandinavica. 2019 Nov;98(11):1429-34.
(27) Hammarberg K, Kirkman M, Pritchard N, Hickey M, Peate M, McBain J, et al. Reproductive experiences of women who cryopreserved oocytes for non-medical reasons. Human Reproduction 2017;32(3):575-581.
(28) Fertilisation H, Authority E. Fertility Treatment 2014-2015 Trends and figures. HFEA Available at https://www.hfea.gov.uk/media/2563/hfea-fertility-trends-and-figures-2017-v2.pdf Accessed 2018;14(08):2018.
(29) Gurtin Z. Unscrambling HFEA data on egg freezing: where are the missing frozen eggs. BioNews 2018:943.
(30) Andersen AN, Wohlfahrt J, Christens P, Olsen J, Melbye M. Maternal age and fetal loss: population based register linkage study. BMJ 2000;320(7251):1708-1712.
(31) Jones BP, Serhal P, Ben Nagi J. Social egg freezing: Early is not always best. Acta Obstet Gynecol Scand 2018;97(12):1531-1531.
(32) Fertilisation H, Authority E. Fertility treatment in 2013: trends and figures. HFEA, London (Available at http://www.hfea.gov.uk/docs/HFEA_Fertility_treatment_ Trends_and_figures_2014.pdf Last accessed: 8 May 2017) 2014.
(33) Bowen-Simpkins P, Wang JJ, Ahuja KK. The UK´ s anomalous 10-year limit on oocyte storage: time to change the law. Reproductive biomedicine online 2018;37(4):387-389.
(34) Nekkebroeck J, Stoop D, Devroey P. O-036 A preliminary profile of women opting for oocyte cryopreservation for non-medical reasons. Human Reproduction 2010;25(20100600).
(35) Greenwood EA, Pasch LA, Hastie J, Cedars MI, Huddleston HG. To freeze or not to freeze: decision regret and satisfaction following elective oocyte cryopreservation. Fertil Steril 2018;109(6):1097-1104. e1.
Table 1 Demographic data and controlled ovarian stimulation variables